FIELD: medicine.
SUBSTANCE: for the purpose of trial of a therapeutic preparation to correct hematological disorders, myelosuppression in simulated in mice by intraperitoneal introduction of cyclophosphane 200 mg/kg once per 7 days for 5 weeks to achieve stable meylosuppression shown by the neutrophil count and the committed granulomonocytopoiesis progenitor count.
EFFECT: method enables studying the possibilities of hematopoietic regeneration and pharmacological correction of the blood system disorders by the multiple cytostatic effect.
1 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
| METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
| HEMOPROTECTIVE AGENT | 2018 |
|
RU2696586C1 |
| MEDICATION OF STIMULATION OF STEM CELL PRODUCTION IN BONE MARROW | 2007 |
|
RU2410116C2 |
| METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
| AGENT STIMULATING ERYTHROIDAL AND GRANULOCYTIC HEMOPOIESIS STEMS IN CYTOSTATIC MYELODEPRESSION | 2003 |
|
RU2243782C1 |
| HEMOSTIMULATING AGENT | 2017 |
|
RU2647833C1 |
| MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
| HEME STIMULATING AGENT | 1994 |
|
RU2094045C1 |
| HEMOPROTECTIVE AGENT | 2019 |
|
RU2725135C1 |
